Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 27;20(1):286.
doi: 10.1186/s13063-019-3394-4.

Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease

Mohammed S Alshahrani  1 , Laila Perlas Asonto  2 , Mohamed M El Tahan  3 , Amal H Al Sulaibikh  4 , Sukayna Z Al Faraj  4 , Abdullah A Al Mulhim  4 , Murad F Al Abbad  4 , Samar A Al Nahhash  4 , Moath N Aldarweesh  4 , Alaa M Mahmoud  4 , Nisreen Almaghraby  4 , Mohammed A Al Jumaan  4 , Thamir O Al Junaid  4 , Faisal M Al Hawaj  4 , Samar AlKenany  4 , Omaima F ElSayed  4 , Haitham M Abdelwahab  4 , Mohamed M Moussa  4 , Bader K Alossaimi  4 , Shaikah K Alotaibi  4 , Talal M AlMutairi  4 , Duaa A AlSulaiman  5 , Saad D Al Shahrani  4 , Donia Alfaraj  4 , Waleed Alhazzani  6
Affiliations

Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease

Mohammed S Alshahrani et al. Trials. .

Abstract

Background: Sickle cell disease (SCD) is an inherited hematological disorder where the shape of red blood cells is altered, resulting in the destruction of red blood cells, anemia, and other complications. SCD is prevalent in the southern and eastern provinces of the Arabian peninsula. The most common complications for individuals with SCD are acute painful episodes that require several doses of intravenous opioids, making pain control for these individuals challenging. Instead of opioids, some studies have suggested that ketamine might be used for pain control in acute pain episodes of individuals with SCD. This study aims to evaluate whether the addition of ketamine to morphine can achieve better pain control, decreasing the number of repeated doses of opiates. We hypothesize that early administration of ketamine would lead to a more rapid improvement in pain score and lower opioid requirements.

Methods and analysis: This study will be a prospective, randomized, concealed, blinded, pragmatic parallel group, controlled trial enrolling adult patients with SCD and acute vaso-occlusive crisis pain. All patients will receive standard analgesic therapy during evaluation. Patients randomized to the treatment arm will receive low-dose ketamine (0.3 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to standard intravenous hydration, while those in the control group will receive a standard dose of morphine (0.1 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to the standard intravenous hydration. All healthcare providers will be blinded to the treatment arm. Data will be analyzed according to the intention-to-treat principle. The primary outcome is improvement in pain severity using the Numerical Pain Rating Score.

Trial registration: Clinicaltrials.gov, NCT03431285 . Registered on 13 February 2018.

Keywords: Acute painful crisis; Ketamine; Randomized control trial; Sickle cell disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Neri CM, Pestieau SR, Young H, et al. Low-dose ketamine for children and adolescents with acute sickle cell disease related pain: a single center experience. J Anesth Clin Res. 2014;5:394. doi: 10.4172/2155-6148.1000394. - DOI
    1. Davis H, Moore RM, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997;112:40–43. - PMC - PubMed
    1. Houston-Yu P, Rana SR, Beyer B, et al. Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients. Am J Hematol. 2003;72:201–203. doi: 10.1002/ajh.10305. - DOI - PubMed
    1. Chu A, Golembiewski J, Molokie RE. Low-dose ketamine infusion in adult patients with sickle cell disease—impact on management of acute painful episodes. Am Soc Hematol. 2013;122:2249.
    1. Uzun B, Kekec Z, Gurkan E. Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis. Am J Emerg Med. 2010;28:445–449. doi: 10.1016/j.ajem.2009.01.016. - DOI - PubMed

Publication types

MeSH terms

Associated data